<?xml version="1.0" encoding="UTF-8"?>
<p>There is increasing interest in harnessing competition to achieve particular public health outcomes, for example, delaying or suppressing the emergence of drug resistance [
 <xref rid="eoaa004-B4" ref-type="bibr">4</xref>]. But competition can take many forms, depending on the mechanistic details of within-host interactions (e.g. direct resource competition, immune-mediated apparent competition and interference competition; [
 <xref rid="eoaa004-B1" ref-type="bibr">1</xref>]) and it is not always clear what form (or forms) are at play in any given system. Does this lack of mechanistic understanding preclude exploiting within-host competition for public health gain?
</p>
